Klein Matthew B. sold PTCT
March 12, 2026 · Form 4 insider transaction
Klein Matthew B. sold 2,662 shares of PTC Therapeutics, Inc. at $64.08 per share, a transaction worth $170.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,662
Price
$64.08
Total value
$170.6K
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 12, 2026
Filing dateMarch 13, 2026
Shares owned after396,920
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the RSU grant to satisfy tax withholding obligations in connection with the vesting of the earned RSUs with respect to 6,500 shares on March 11, 2026.